MARATTO

article · ARCADEs of MEDICINE

The value of Neutrophils to Lymphocytes ratio and Platelets to Lymphocytes ratio as a prognostic factor for post-neoadjuvant chemotherapy residual disease in advanced ovarian cancer

2025Open accessSuez University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer, Lipids, and Metabolism
  • Ovarian cancer diagnosis and treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/arcmed.2025.357721.1089

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.